Daniel Snzile Ndima
Ndima is a structural biologist and protein engineer. He specializes in crystallography, bioprocess engineering and biomanufacturing. He holds a bachelor’s degree in Biotechnology and a master’s degree in Biochemistry (Structural Biology) from University of the Western Cape and University of Pretoria, respectively. Ndima is founding CEO of CapeBio Technologies (CapeBio), a new South African applied genomics and biotech company that develops Life Science tools and molecular biology reagent enzymes kits to empower African Scientists, Research and Development (R&D) institutions and companies to innovate in their respective disciplines. Through this company, Ndima and his team developed a disruptive technology of a rapid test kit for the SARS-CoV-2 virus in 2020. The kit produces test results in just 65 minutes as compared to other technologies that take at least 3 hours. As of 2020, the kit is under assessment and validation for mass scale replication and use. Ndima has many accolades to his name including being a fellow of the prestigious Allan Gray Orbis Foundation, Mandela Rhodes Scholar (Class of 2015) and a Brightest Young Minds (BYM2016) Alumnus.